Montelukast significantly improves QOL as well as nasal congestion, rhinorrhea, sneezing, and nasal itching in patients with perennial allergic rhinitis (PAR) and is persistently effective over 6 weeks

Author:  

Publisher: Adis International

ISSN: 1173-5503

Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.497, 2006-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract